Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial

Jinjing Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofeng Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongtao Jin(Hebei Medical University), Xiaofei Shi(Shanghai First Maternity and Infant Hospital), Hui Luo(Jiangxi Provincial Cancer Hospital), Xinwang Duan(Nanchang University), Zhenggui Du(Yuncheng University), Huaxiang Liu(Qilu Hospital of Shandong University), Qibing Xie(Sichuan University), Shangzhu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiuqin Geng(Xinxiang Central Hospital), Huiping Gong(Changzhi Medical College Peace Hospital), Rui Wu(Nanchang University), Cundong Mi(Guangxi Medical University), Xi Xie(Central South University), Yuqi Sun(Jiangsu Hengrui Medicine (China)), Wei Hua(Northern Jiangsu People's Hospital), Ying Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Chen(Chinese PLA General Hospital), Ning Zhang(China Medical University), Zhaohui Zheng(Xijing Hospital), Jian Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenyu Jiang(Jilin University), Lei Yang(Zhengzhou Central Hospital), Yasong Li(Fujian Medical University), Shengyun Liu(First Affiliated Hospital of Zhengzhou University), Jing Zhu(Fudan University), Changsong Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Feng Zhan(Hainan General Hospital), Xiaohong He(Guangzhou University of Chinese Medicine), Jingbo Su(First Affiliated Hospital of Zhengzhou University), Guangchao Dong(Jiangsu Hengrui Medicine (China)), Shengqian Xu(Anhui Medical University), Jing Liu(China Medical University), Long Qian(Anhui Medical University)
Annals of the Rheumatic Diseases
February 1, 2025
10.1136/ard-2024-226385
Cited by 17

Related Papers

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury
|Journal of Neuroinflammation|2018|267
<i>Arabidopsis</i> COP10 forms a complex with DDB1 and DET1 in vivo and enhances the activity of ubiquitin conjugating enzymes
|Genes & Development|2004|206